Processing of urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro.
Open Access
- 1 May 1994
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 93 (5), 2039-2047
- https://doi.org/10.1172/jci117198
Abstract
The antigen processing requirements for urushiol, the immunogen of poison ivy (Toxicodendron radicans), were tested by presentation of urushiol to cultured human urushiol-responsive T cells. Urushiol was added to antigen-presenting cells (APC) either before or after fixation with paraformaldehyde. Three distinct routes of antigen processing were detected. CD8+ and CD4+ T cells, which were dependent upon processing, proliferated if urushiol was added to APC before fixation, but did not proliferate when urushiol was added to APC after fixation. Processing of urushiol for presentation to CD8+ T cells was inhibited by azide, monensin, and brefeldin A. This suggests that urushiol was processed by the endogenous pathway. In contrast, presentation of urushiol to CD4+ T cells was inhibited by monensin but not by brefeldin A. This was compatible with antigen processing by the endosomal (exogenous) pathway. Finally, certain CD8+ T cells recognized urushiol in the absence of processing. These cells proliferated in response to APC incubated with urushiol after fixation. Classification of contact allergens by antigen processing pathway may predict the relative roles of CD4+ and CD8+ cells in the immunopathogensis of allergic contact dermatitis.This publication has 45 references indexed in Scilit:
- Predominance of Epidermal CD8+ T Lymphocytes in Bullous Cutaneous Reactions Caused by β-Lactam AntibioticsJournal of Investigative Dermatology, 1993
- Role of hapten-anchoring peptides in defining hapten-epitopes for MHC-restricted cytotoxic T cells. Cross-reactive TNP-determinants on different peptides.The Journal of Immunology, 1992
- Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens.The Journal of Immunology, 1992
- The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.The Journal of Immunology, 1992
- Ham-2 corrects the class I antigen-processing defect in RMA-S cellsNature, 1992
- Brefeldin A Specifically Inhibits Presentation of Protein Antigens to Cytotoxic T LymphocytesScience, 1989
- Quantitation and Cloning of Human Urushiol Specific Peripheral Blood T-Cells: Isolation of Urushiol Triggered Suppressor T-CellsJournal of Investigative Dermatology, 1989
- Processing requirements for T cell activation by Mycoplasma arthritidis‐derived mitogenEuropean Journal of Immunology, 1988
- EVIDENCE FOR AN ARENE OXIDE NIH SHIFT PATHWAY IN THE METABOLIC CONVERSION OF PHENYTOIN TO 5-(4-HYDROXYPHENYL)-5-PHENYLHYDANTOIN IN THE RAT AND IN MAN1982
- Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.Proceedings of the National Academy of Sciences, 1978